Headshot of André Fenton.

André Fenton

Professor, New York University
Contributing editor, The Transmitter

André Fenton is professor of neural science and director of the Center for Neural Science at New York University. He investigates the molecular, neural, behavioral and computational aspects of memory. He studies how brains store experiences as memories, how they learn to learn, and how knowing activates relevant information without activating what is irrelevant. These investigations are founded in how the brain computes knowledge of space, particularly the locations and directions that are the framework for experience. His investigations integrate across levels of biological organization; his research uses genetic, molecular, electrophysiological, imaging, behavioral, engineering and theoretical methods. This computational psychiatry research is helping to elucidate mental dysfunction in diverse conditions, including schizophrenia, autism, and depression.

Fenton founded BioSignal Group, Corp., which commercialized an FDA-approved portable, wireless and easy-to-use platform for recording EEGs in novel medical applications. He implemented a CPAP-oxygen-helmet treatment for COVID-19 in Nigeria and other low- and middle-income countries, and he develops information technology for the patient-centric coordination of behavioral health services that is desperately needed to equitably deliver care for mental health. Fenton hosted PBS’ “NOVA Wonders,” and he chairs the National Institute of Mental Health’s Board of Scientific Counselors.

Explore more from The Transmitter

Research image of lesion network mapping.

‘Overdue’ debate unfurls over neuroimaging method

After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.

By Angie Voyles Askham
17 April 2026 | 8 min read
Research image of zebrafish brain activity.

Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish

Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.

By Charles Q. Choi
16 April 2026 | 4 min read
NINDS building.

What neuroscientists want from a new NINDS director

The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”

By Helena Kudiabor
15 April 2026 | 4 min read